Takara Bio

Takara Bio Assets per Share

Delisted

The Total Assets per Share of Takara Bio (4974.T) as of Oct 29, 2026 is 1,040.85 JPY. In the previous year, Total Assets per Share was 1,006.95 JPY — a change of 3.37% (higher).

Assets per Share

1,040.85JPY

YoY

3.37%

Last updated:

Total Assets per Share of Takara Bio is 2025 1,040.85 JPY. Total Assets per Share of Takara Bio was 2024 1,006.95 JPY. It decreases by 3.37% higher compared to the previous year.

The Takara Bio Assets per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Assets per Share
Date
Assets per Share
Jan 1, 2018
570.28 JPY
Jan 1, 2019
589.96 JPY
Jan 1, 2020
622.92 JPY
Jan 1, 2021
745.34 JPY
Jan 1, 2022
960.94 JPY
Jan 1, 2023
1,072.97 JPY
Jan 1, 2024
1,006.95 JPY
Jan 1, 2025
1,040.85 JPY
The Takara Bio Assets per Share history
YEARAssets per ShareYoY
1,040.85JPY+3.37%
1,006.95JPY-6.15%
1,072.97JPY+11.66%
960.94JPY+28.93%
745.34JPY+19.65%
622.92JPY+5.59%
589.96JPY+3.45%
570.28JPY+2.27%
557.59JPY+0.83%
553.01JPY+0.25%
551.63JPY+6.28%
519.04JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Takara Bio Stock analysis

What does Takara Bio do? Takara Bio Inc is a Japanese biotechnology company that has been active in the medical and life science industry since its founding in 1967. The company is a strong player in the field of molecular biology and operates in several countries such as the USA, Europe, and Asia. Takara Bio Inc was established as an independent company in 1999, focusing exclusively on the production of molecular biology products. The company offers a wide range of products in the fields of research and diagnostics, including enzymes, PCR kits, vectors and plasmids, antibodies, proteins, and cell culture products. Takara Bio Inc is organized into two divisions: Life Science Research and Diagnostics. The Life Science Research division provides products and solutions for research and development in areas such as molecular biology, neuroscience, proteomics, and genomics. The Diagnostics division offers products and solutions for clinical diagnostics and drug development. Takara Bio Inc also specializes in the automation of molecular biology procedures and offers automated systems that can perform processes such as nucleic acid extraction, PCR, and sequencing. The company is committed to sustainability and environmental protection, adhering to strict environmental and quality standards in its production processes and implementing waste reduction and efficient resource utilization programs. Overall, Takara Bio Inc is a leading company in the field of molecular biology, offering a wide range of products and solutions for research and diagnostics, and has become a key player in the life science industry through its global expansion and ability to provide custom solutions. Takara Bio is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Takara Bio stock

Total Assets per Share of Takara Bio is 1,040.85 JPY in 2025.

Total Assets per Share of Takara Bio changed from 1,006.95 JPY to 1,040.85 JPY, representing a 3.37% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Assets per Share Takara Bio since 2006 – with annual values, charts, and detailed analysis.

Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — Takara Bio

All Key Metrics — Takara Bio